Noninvasive prenatal testing: The paradigm is shifting rapidly

Prenatal Diagnosis

Volumn 33, Issue 6, 2013, Pages 511-513

  Chitty, Lyn S ^a   Bianchi, Diana W ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN D ANTIBODY;

ANEUPLOIDY; CHROMOSOME REARRANGEMENT; CONGENITAL ADRENAL HYPERPLASIA; DNA SEQUENCE; EDITORIAL; FETUS CELL; GENE SEQUENCE; HEALTH CARE QUALITY; HIGH RISK PREGNANCY; HUMAN; IMMUNOPROPHYLAXIS; NON INVASIVE PROCEDURE; NONINVASIVE PRENATAL TESTING; PRENATAL CARE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; SEX DETERMINATION;

DNA; FEMALE; FETAL DISEASES; FETOSCOPY; FETUS; GENETIC TESTING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; TIME FACTORS;

EID: 84878144362     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4136     Document Type: Editorial

References (41)

1. Bianchi DW. From Michael to microarrays: 30years of studying fetal cells and nucleic acids in maternal blood. Prenat Diagn 2010;30:622-623.
2. Mouawia H, Saker A, Jais JP, et al. Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy. Reprod Biomed Online 2012;25(5):508-520.
3. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350(9076):485-487.
4. Devaney SA, Palomaki GE, Scott JA, et al. Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA 2011;306:627-636.
5. Finning KM, Martin PG, Soothill PW, et al. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion. 2002;42(8):1079-1085.
6. Oxenford K, Silcock C, Hill M, Chitty L. Routine testing of fetal Rhesus D status in Rhesus D negative women using a cell-free fetal DNA: an investigation into the preferences and information needs of women. Prenat Diagn 2013, DOI: 10.1002/pd.4135
7. Clausen FB, Christiansen M, Steffensen R, et al. Report of the first nationally implemented clinical routine screening for fetal RHD in D-pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 2012;52:752-758.
8. Hill M, Lewis C, Jenkins L, et al. Implementing noninvasive prenatal fetal sex determination using cell-free fetal DNA in the United Kingdom. Expert Opin Biol Ther 2012;12 Suppl 1:S119-S126.
9. Lewis C, Hill M, Skirton H, et al. Fetal sex determination using cell-free fetal DNA: service users' experiences of and preferences for service delivery. Prenat Diagn 2012;32:735-741.
10. Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem 2007; 7576-7579.
11. Lo YM, Lun FM, Chan KC, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A 2007;104:13116-13121.
12. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A. 2008;105:16266-16271.
13. Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008;105:20458-20463.
14. Chetty S, Garabedian MJ, Norton ME. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 2013;33:542-6.
15. Musci TJ, Fairbrother G, Batey A, et al. Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice. Prenat Diagn 2013;33:424-428.
16. Walsh JME, Goldberg JD. Fetal aneuploidy detection by maternal plasma DNA sequencing: a technology assessment. Prenat Diagn 2013;33:514-20.
17. Benn P, Borrell A, Cuckle H, et al. Prenatal detection of Down syndrome using massively parallel sequencing (PS): a rapid response statement from a committee on behalf of the Board of International Society for Prenatal Diagnosis, 24 October 2011. Prenat Diagn 2012;32:1-2.
18. The American College of Obstetricians and Gynecologists Committee on Genetics. The Society for Maternal-Fetal medicine publications committee. Noninvasive prenatal testing for fetal aneuploidy. Committee opinion 545, 2012
19. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screen for fetal aneuploidy. Genet Med 2013 doi.10.1038/gim.2013.29.
20. Agarwal A, Sayres, LC, Cho MK, et al. Commercial landscape of noninvasive prenatal testing in the United States. Prenat Diagn 2013;33:521-31.
21. Skirton H, Patch C. Factors affecting the clinical use of non-invasive prenatal testing: a mixed methods systematic review. Prenat Diagn 2013;33:532-41.
22. Boon EMJ, Faas BHW. Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies. Prenat Diagn 2013;33:563-8.
23. Fairbrother G, Johnson S, Musci TJ, et al. clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population. Prenat Diagn 2013;33:1-5.
24. Futch T, Spinosa J, Bhatt S, et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013;33:569-74.
25. Pan M, Li FT, Li Y, et al. Discordant results between fetal karyotyping and non-invasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue. Prenat Diagn 2013;33:1-4.
26. Lau TK, Jiang FM, Stevenson RJ, et al. Secondary findings from non-invasive prenatal testing from common fetal aneuploidies by whole genome sequencing as a clinical service. Prenat Diagn 2013;33:602-8.
27. Searle CJ, Smith K, Daniels G, et al. Cell-free fetal DNA sex determination identified a maternal SRY gene with a known X chromosome deletion. Prenat Diagn 2013;33:612-3.
28. Osborne CM, Hardisty E, Devers P, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013;33:609-11.
29. Nicolaides KH, Syngelaki A, Gil M, et al. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn 2013;33:575-9.
30. Mazloom AR, Džakula Ž, Oeth P, et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn 2013;33:591-7.
31. Guex N, Iseli C, Syngelaki A, et al. A robust second-generation genome-wide test for fetal aneuploidy based on shotgun sequencing cell-free DNA in maternal blood. Prenat Diagn 2013, DOI: 10.1002/pd.4130
32. Stumm M, Entezami M, Haug K, et al. Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe. Prenat Diagn, in press.
33. Chen S, Lau TK, Zhang C, et al. A method for non-invasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn 2013;33:584-90.
34. Leung TY, Qu JZZ, Liao GJW, et al. Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing. Prenat Diagn 2013, DOI: 10.1002/pd.4132
35. Canick JA, Palomaki GE, Kloza EM, et al. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn 2013, DOI: 10.1002/pd.4126
36. Wang E, Batey A, Struble C, et al. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn 2013, DOI: 10.1002/pd.4119
37. Papantoniou N, Bagiokos V, Agiannitopoulos K, et al. RASSF1A in maternal plasma as a molecular marker of preeclampsia. Prenat Diagn 2013, DOI: 10.1002/pd.4093
38. Lench N, Barrett A, Fielding S, et al. The clinical implementation of non-invasive prenatal diagnosis for single gene disorders: challenges and progress made. Prenat Diagn 2013;33:555-62.
39. Snyder MW, Simmons LE, Kitzman JO, et al. Noninvasive fetal genome sequencing: a primer. Prenat Diagn 2013;33:547-54.
40. Mehta V, Abi Nader K, Waddington S, et al. Organ targeted prenatal gene therapy - how far are we? Prenatal Diagn 2011;31:720-734.
41. Guedj F, Bianchi DW. Noninvasive prenatal testing creates an opportunity for antental treatment of Down syndrome. Prenat Diagn 2013;33:614-8.